Paper39720886
Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids.
Chen Q and 2 others. ACS Chem Neurosci, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids. Papers, record 39720886. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39720886
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Competitive Antagonism of Xylazine on α7 Nicotinic Acetylcholine Receptors and Reversal by Curcuminoids.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| alpha7 Nicotinic Acetylcholine Receptor | Major topic |
| Xylazine | Major topic |
| Adrenergic alpha-2 Receptor Antagonists | Major topic |
| Animals | |
| Rats | |
| Xenopus laevis | |
| PC12 Cells | |
| Oocytes | |
| Humans | |
| Acetylcholine |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA046939 | NIDA NIH HHS | United States | R01DA046939 | PubMed and NIH | NIH RePORTER |
| R01 NS122830 | NINDS NIH HHS | United States | R01NS122830 | PubMed and NIH | NIH RePORTER |
| U54 DK137329 | NIDDK NIH HHS | United States | U54DK137329 | PubMed and NIH | NIH RePORTER |
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34301823 | Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34301823 | PubMed |
| 2 | 24672232 | Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. | Clin Interv Aging | 2014 | https://conductscience.org/library/papers/24672232 | PubMed |
| 3 | 31132111 | Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. | J Nutr | 2019 | https://conductscience.org/library/papers/31132111 | PubMed |
| 4 | 22743772 | Fiji: an open-source platform for biological-image analysis. | Nat Methods | 2012 | https://conductscience.org/library/papers/22743772 | PubMed |
| 5 | 26066335 | Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. | J Clin Psychopharmacol | 2015 | https://conductscience.org/library/papers/26066335 | PubMed |
| 6 | 33478095 | Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33478095 | PubMed |
| 7 | 23425071 | Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/23425071 | PubMed |
| 8 | 27470399 | Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. | Biomed Pharmacother | 2016 | https://conductscience.org/library/papers/27470399 | PubMed |
| 9 | 31333398 | Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31333398 | PubMed |
| 10 | 27402494 | Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. | Neuropsychopharmacology | 2017 | https://conductscience.org/library/papers/27402494 | PubMed |
| 11 | 32162523 | Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32162523 | PubMed |
| 12 | 26648784 | Role of α7 nicotinic receptor in the immune system and intracellular signaling pathways. | Cent Eur J Immunol | 2015 | https://conductscience.org/library/papers/26648784 | PubMed |
| 13 | 33958730 | Structural basis of human α7 nicotinic acetylcholine receptor activation. | Cell Res | 2021 | https://conductscience.org/library/papers/33958730 | PubMed |
| 14 | 7545885 | Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells. | Ann N Y Acad Sci | 1995 | https://conductscience.org/library/papers/7545885 | PubMed |
| 15 | 36538321 | Warning About Xylazine, a Veterinary Sedative Found in Illicit Drugs. | JAMA | 2022 | https://conductscience.org/library/papers/36538321 | PubMed |
| 16 | 28092663 | Neural regulation of immunity: molecular mechanisms and clinical translation. | Nat Neurosci | 2017 | https://conductscience.org/library/papers/28092663 | PubMed |
| 17 | 38401117 | Curcumin - Bioavailability Enhancement by Prodrug Approach and Novel Formulations. | Chem Biodivers | 2024 | https://conductscience.org/library/papers/38401117 | PubMed |
| 18 | 31227712 | α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. | Nat Commun | 2019 | https://conductscience.org/library/papers/31227712 | PubMed |
| 19 | 25907239 | Non-neuronal cholinergic system in regulation of immune function with a focus on α7 nAChRs. | Int Immunopharmacol | 2015 | https://conductscience.org/library/papers/25907239 | PubMed |
| 20 | 28285851 | Ivermectin - Old Drug, New Tricks? | Trends Parasitol | 2017 | https://conductscience.org/library/papers/28285851 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42633410 | Interpol review of forensic drug chemistry, 2022-2025. | Forensic Sci Int Synerg | 2026 | https://conductscience.org/library/papers/42633410 | PubMed |
| 42556608 | Xylazine reduces methamphetamine-induced hyperlocomotion in rats through κ-opioid and α2-adrenoceptor mechanisms. | Neurosci Lett | 2026 | https://conductscience.org/library/papers/42556608 | PubMed |
| 40619654 | Next-Generation Phospholipid Nanocomplexes for Precision Neurotherapeutics: Harnessing Endogenous Blood-Brain Barrier Transport Mechanisms to Revolutionize the Treatment of Neurodegenerative Diseases. | Recent Adv Drug Deliv Formul | 2026 | https://conductscience.org/library/papers/40619654 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADORA2A | 135 | PubTator's text mining | https://conductscience.org/library/genes/135 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39720886
GET https://conductscience.org/api/papers/v1/39720886/references?page=2